Recent Advances in IRAK1: Pharmacological and Therapeutic Aspects

被引：10

作者：

Kim, Kyeong Min ^{[1
]}

Hwang, Na-Hee ^{[1
]}

Hyun, Ja-Shil ^{[1
]}

Shin, Dongyun ^{[1
]}

机构：

[1] Gachon Univ, Coll Pharm, Hambakmoe Ro 191, Incheon 21935, South Korea

来源：

MOLECULES | 2024年 / 29卷 / 10期

基金：

新加坡国家研究基金会;

关键词：

interleukin receptor-associated kinase (IRAK) proteins; inhibitor; degrader; immunity; SIGNALING MEDIATOR; KINASE IRAK; INNATE; ACTIVATION; INFLAMMATION; INHIBITORS; FAMILY; NEUROINFLAMMATION; IDENTIFICATION; MICRORNA-146A;

D O I：

10.3390/molecules29102226

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Interleukin receptor-associated kinase (IRAK) proteins are pivotal in interleukin-1 and Toll-like receptor-mediated signaling pathways. They play essential roles in innate immunity and inflammation. This review analyzes and discusses the physiological functions of IRAK1 and its associated diseases. IRAK1 is involved in a wide range of diseases such as dry eye, which highlights its potential as a therapeutic target under various conditions. Various IRAK1 inhibitors, including Pacritinib and Rosoxacin, show therapeutic potential against malignancies and inflammatory diseases. The covalent IRAK1 inhibitor JH-X-119-01 shows promise in B-cell lymphomas, emphasizing the significance of covalent bonds in its activity. Additionally, the emergence of selective IRAK1 degraders, such as JNJ-101, provides a novel strategy by targeting the scaffolding function of IRAK1. Thus, the evolving landscape of IRAK1-targeted approaches provides promising avenues for increasingly safe and effective therapeutic interventions for various diseases.

引用

页数：17

共 100 条

[11] Pacritinib Inhibition of IRAK1 Blocks Aberrant TLR8 Signalling by SARS-CoV-2 and HIV-1-Derived RNA [J].

Campbell, Grant R. ;

Rawat, Pratima ;

Spector, Stephen A. .

JOURNAL OF INNATE IMMUNITY, 2023, 15 (01) :96-106

[12] Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases [J].

Carsetti, Rita ;

Zaffina, Salvatore ;

Mortari, Eva Piano ;

Terreri, Sara ;

Corrente, Francesco ;

Capponi, Claudia ;

Palomba, Patrizia ;

Mirabella, Mattia ;

Cascioli, Simona ;

Palange, Paolo ;

Cuccaro, Ilaria ;

Milito, Cinzia ;

Zumla, Alimuddin ;

Maeurer, Markus ;

Camisa, Vincenzo ;

Vinci, Maria Rosaria ;

Santoro, Annapaola ;

Cimini, Eleonora ;

Marchioni, Luisa ;

Nicastri, Emanuele ;

Palmieri, Fabrizio ;

Agrati, Chiara ;

Ippolito, Giuseppe ;

Porzio, Ottavia ;

Concato, Carlo ;

Muda, Andrea Onetti ;

Raponi, Massimiliano ;

Quintarelli, Concetta ;

Quinti, Isabella ;

Locatelli, Franco .

FRONTIERS IN IMMUNOLOGY, 2020, 11

[13] IRAK1-Dependent Signaling Mediates Mortality in Polymicrobial Sepsis [J].

Chandra, Rachna ;

Federici, Stephanie ;

Bishwas, Tripti ;

Nemeth, Zoltan H. ;

Deitch, Edwin A. ;

Thomas, James A. ;

Spolarics, Zoltan .

INFLAMMATION, 2013, 36 (06) :1503-1512

[14] Downregulation of IRAK1 Prevents the Malignant Behavior of Hepatocellular Carcinoma Cells by Blocking Activation of the MAPKs/NLRP3/IL-1β Pathway [J].

Chen, Wei ;

Wei, Tao ;

Chen, Yinghua ;

Yang, Lan ;

Wu, Xiaomin .

ONCOTARGETS AND THERAPY, 2020, 13 :12787-12796

[15] Interleukin-1 receptor-associated kinase 4 (IRAK4) plays a dual role in myddosome formation and Toll-like receptor signaling [J].

De Nardo, Dominic ;

Balka, Katherine R. ;

Gloria, Yamel Cardona ;

Rao, Vikram R. ;

Latz, Eicke ;

Masters, Seth L. .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (39) :15195-15207

[16] A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells [J].

Dillon, S ;

Agrawal, A ;

Van Dyke, T ;

Landreth, G ;

McCauley, L ;

Koh, A ;

Maliszewski, C ;

Akira, S ;

Pulendran, B .

JOURNAL OF IMMUNOLOGY, 2004, 172 (08) :4733-4743

[17] Small molecules targeting the innate immune cGAS-STING-TBK1 signaling pathway [J].

Ding, Chunyong ;

Song, Zilan ;

Shen, Ancheng ;

Chen, Tingting ;

Zhang, Ao .

ACTA PHARMACEUTICA SINICA B, 2020, 10 (12) :2272-2298

[18] INVITRO ANTI-MICROBIAL ACTIVITY OF ROSOXACIN AGAINST NEISSERIA-GONORRHOEAE, CHLAMYDIA-TRACHOMATIS, AND UREAPLASMA-UREALYTICUM [J].

DOBSON, RA ;

OCONNOR, JR ;

POULIN, SA ;

KUNDSIN, RB ;

SMITH, TF ;

CAME, PE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 18 (05) :738-740

[19] Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy [J].

Fakhoury, Marc .

CURRENT NEUROPHARMACOLOGY, 2018, 16 (05) :508-518

[20] Cutting Edge: TLR Signaling Licenses IRAK1 for Rapid Activation of the NLRP3 Inflammasome [J].

Fernandes-Alnemri, Teresa ;

Kang, Seokwon ;

Anderson, Connor ;

Sagara, Junji ;

Fitzgerald, Katherine A. ;

Alnemri, Emad S. .

JOURNAL OF IMMUNOLOGY, 2013, 191 (08) :3995-3999

← 1 2 3 4 5 6 7 8 9 10 →